Subscribe
The latest psychology and neuroscience discoveries.
My Account
  • Mental Health
  • Social Psychology
  • Cognitive Science
  • Psychopharmacology
  • Neuroscience
  • About
No Result
View All Result
PsyPost
PsyPost
No Result
View All Result
Home Exclusive Mental Health Dementia Alzheimer's Disease

Is it really possible to have Alzheimer’s yet no symptoms?

by Michael Hornberger
July 16, 2024
in Alzheimer's Disease
(Photo credit: Adobe Stock)

(Photo credit: Adobe Stock)

Share on TwitterShare on Facebook
Stay informed on the latest psychology and neuroscience research—follow PsyPost on LinkedIn for daily updates and insights.

Some people seem to be more resilient to developing Alzheimer’s diseases, despite having the biological hallmarks of the devastating disease. For obvious reasons, scientists are very interested in studying this special group of people.

Alzheimer’s disease, the most common form of dementia, is thought to start because of a build-up of two proteins in the brain: amyloid and tau. Once these proteins accumulate, for yet-to-be-determined reasons, they become toxic to brain cells (neurons) and these cells start dying. As a result, people develop symptoms such as memory loss because the brain can’t function properly with all these dead neurons.

This cascade of events has been known for many years and is how the disease progresses in most people with Alzheimer’s. Most people, except a special group who are more resilient. But why are they resilient?

A recent study in the journal Acta Neuropathologica Communications investigated whether our genes might influence how resilient we are against Alzheimer’s disease symptoms when there are high levels of amyloid in our brain.

The scientists conducted a study on the brains of three groups of people. The first group comprised people who had died with Alzheimer’s disease. The second were healthy people who died of natural causes. And the third comprised people who had high levels of Alzheimer’s proteins in the brain but never developed symptoms of the disease during their lifetime – or at least never had a diagnosis of Alzheimer’s disease.

The last group, they considered as being resilient to Alzheimer’s disease since they had the proteins in their brains but did not have the symptoms or a diagnosis of Alzheimer’s disease during their lifetime.

The scientists found that genes related to the activity of the immune system seem to have been more active in the Alzheimer’s resilient group. This would make sense as it is well established that the immune system helps clear the excess proteins from the brain, so genes that help this process might make us more resilient to developing symptoms of the disease.

How to become resilient – even if you don’t have the genes

This is great if you have inherited these genes from your parents, but what does it mean for the rest of us who do not have those genes? Is there a way we can make ourselves more resilient to developing Alzheimer’s disease regardless of our genes?

“Yes” is the short answer.

There is now good scientific evidence that lifestyle changes and drugs allow us to reduce our risk of developing Alzheimer’s disease in the future.

In particular, physical activity has been shown to reduce our risk of developing Alzheimer’s, probably because it has a well-known beneficial effect on our immune system and hence helps clear those rogue proteins accumulating in our brains. This means that being more physically active might have the same effect on our Alzheimer’s resilience as those lucky people who have the “right” genes.

Interestingly, we do not know how physically active the resilient people in the study were and how this might have influenced their resilience to Alzheimer’s disease.

As so often in science, it is not clear whether nature (genes) or nurture (lifestyle) contributed to their resilience. The other interesting aspect is that the resilient people in the study died of another cause than Alzheimer’s disease, but they might have developed Alzheimer’s disease eventually if they had lived longer.The Conversation

 

This article is republished from The Conversation under a Creative Commons license. Read the original article.

TweetSendScanShareSendPin1ShareShareShareShareShare

RELATED

Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests
Alzheimer's Disease

Poor sleep may shrink brain regions vulnerable to Alzheimer’s disease, study suggests

June 14, 2025

Spending less time in slow wave and REM sleep may accelerate brain atrophy in regions affected early in Alzheimer’s disease, according to new research. The findings support sleep quality as a potential factor in preserving brain health.

Read moreDetails
Neuroscience discoveries: 5 new studies offer unexpected insights into the brain
Alzheimer's Disease

Common sleep aid blocks brain inflammation and tau buildup in Alzheimer’s model

June 13, 2025

Scientists have found that lemborexant not only increased restorative sleep in male mice but also reduced levels of toxic tau and brain inflammation. The findings suggest that targeting the brain’s orexin system may help slow Alzheimer’s progression.

Read moreDetails
Older adults adhering to Mediterranean diet have 11% lower odds of developing dementia, study finds
Alzheimer's Disease

Mediterranean diet appears to weaken the depression–Alzheimer’s connection

June 7, 2025

A new study suggests that the Mediterranean diet may reduce the biological impact of depression on the brain. In older men, depressive symptoms were linked to higher Alzheimer’s biomarkers—except in those with strong adherence to a Mediterranean-style diet.

Read moreDetails
Beta blockers: how these common heart medications may reduce the risk of violence
Alzheimer's Disease

Long-term SSRI use linked to reduced Alzheimer’s pathology but mixed effects on cognition

May 29, 2025

A new study suggests long-term SSRI use may reduce markers of Alzheimer’s disease and restore brain function in affected regions, but the impact on cognitive performance remains mixed depending on how it’s measured.

Read moreDetails
Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity
Alzheimer's Disease

Cannabidiol shows promise for treating Alzheimer’s in mice by targeting brain hyperactivity

May 26, 2025

In a study using an Alzheimer’s disease mouse model, researchers found that cannabidiol reduced memory loss and brain abnormalities. The compound worked by enhancing the function of glycine receptors, which help regulate neuronal activity in the brain's memory center.

Read moreDetails
A common childhood virus could be silently fueling Alzheimer’s disease in old age
Alzheimer's Disease

A common childhood virus could be silently fueling Alzheimer’s disease in old age

May 25, 2025

A virus best known for causing cold sores may dramatically increase the risk of Alzheimer’s in people with a specific gene variant. New evidence suggests herpes reactivation in the brain may trigger the destructive changes seen in the disease.

Read moreDetails
Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data
Alzheimer's Disease

Scientists find 16 new Alzheimer’s-linked genes using multi-ancestry genome data

May 23, 2025

A groundbreaking genome-wide analysis has revealed new genetic regions associated with Alzheimer’s disease—many missed in past studies focused on European populations. The findings point to underexplored biological pathways and highlight the value of studying diverse ancestry groups.

Read moreDetails
New eye test may detect Alzheimer’s disease years before symptoms emerge, study suggests
Alzheimer's Disease

New eye test may detect Alzheimer’s disease years before symptoms emerge, study suggests

May 18, 2025

A low-cost, noninvasive eye scan could help detect Alzheimer’s disease earlier than current methods. The technique may expand access to early diagnosis, especially in underserved communities, and provide a valuable tool for intervention before irreversible brain damage occurs.

Read moreDetails

SUBSCRIBE

Go Ad-Free! Click here to subscribe to PsyPost and support independent science journalism!

STAY CONNECTED

LATEST

Could creatine slow cognitive decline? Mouse study reveals promising effects on brain aging

ChatGPT and “cognitive debt”: New study suggests AI might be hurting your brain’s ability to think

Frequent dreams and nightmares surged worldwide during the COVID-19 pandemic

Vagus nerve signals influence food intake more in higher socio-economic groups

People who think “everyone agrees with me” are more likely to support populism

What is the most attractive body fat percentage for men? New research offers an answer

Longer antidepressant use linked to more severe, long-lasting withdrawal symptoms, study finds

New psychology study sheds light on mysterious “feelings of presence” during isolation

         
       
  • Contact us
  • Privacy policy
  • Terms and Conditions
[Do not sell my information]

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

Subscribe
  • My Account
  • Cognitive Science Research
  • Mental Health Research
  • Social Psychology Research
  • Drug Research
  • Relationship Research
  • About PsyPost
  • Contact
  • Privacy Policy